Huntington's Disease

Question 1

Huntington’s disease (HD)

Answer 1

relatively rare, inherited neurodegenerative disorder

Question 2

Worldwide prevalence of 5 per 100,000

Answer 2

(Medina et al. 2022)

Question 3

HD is a repeat length expansion disorder

Answer 3

caused by mutation in the huntingtin (HTT) gene, the function of which remains relatively unclear

Question 4

Consequential polyglutamine (CAG) expansion leads to

Answer 4

accumulation of mutant Htt protein (mHtt) and the formation of dense, intraneuronal inclusion bodies which ultimately compromise cell viability and neuronal survival

Question 5

Mean age of HD onset is 30-50 years with a mean life expectancy of

Answer 5

17-20 years

Question 6

In some cases, symptoms can present prior to 20 years of age

Answer 6

with juvenile HD associated with behaviour disturbances and learning difficulties at school

Question 7

HD is primarily characterised by motor, cognitive and psychiatric disturbances

Answer 7

with metabolic and mitochondrial dysfunction commonly observed in HD patients as well as an aberrant inflammatory response

Question 8

Motor symptoms are perhaps the most common manifestation of HD

Answer 8

with Huntington’s chorea defined as non-rhythmic jerking movements of arms and legs

Question 9

Can also include facial grimacing as well as

Answer 9

shoulder raising and finger extension

Question 10

Chorea is present while the individual is awake however

Answer 10

absence of unwanted movements during sleep is postulated to involve the anti-inflammatory role of sleep

Question 11

As HD progresses

Answer 11

difficulties with talking and swallowing can lead to choking as well as patients becoming mute

Question 12

Mild cognitive symptoms may initially appear in forms of irritability depression and incoordination

Answer 12

which eventually progresses towards dementia and epileptic seizures

Question 13

Psychiatric disturbances may be present during the pre-manifest stage

Answer 13

with apathy the only neuropsychiatric symptom shown to consistently progress with disease

Question 14

Suicide rates are the second most common death in HD

Answer 14

following respiratory complications

Question 15

The anatomical basis of chorea is believed to be the basal ganglia (BG)

Answer 15

where HD brains present with enlargement of the lateral ventricles and thus atrophy of the dorsal striatal regions, the caudate and the putament.

Question 16

Associated degeneration in the frontal and temporal cortices is potentially the cause of

Answer 16

behavioural and cognitive deficits

Question 17

A 5 grade classification system exists for HD pathology

Answer 17

grade 0 - demonstrates clinical evidence for HD without microscopic abnormalities

grade 4 - characterised by shrunken yellow-brown caudate with widened anterior horn of lateral ventricle and smaller nucleus accumbens

Question 18

MRI advances have confirmed early pathological findings of grey matter volume decline

Answer 18

in caudate and putamen and loss of white matter in striatum and cortex

Question 19

The pathophysiological mechanism behind hyperkinetic activity in HD involves

Answer 19

degeneration of medium spiny GABAergic interneurons of the caudate and putamen

Question 20

Loss of these inhibitory projections to the external globus pallidus

Answer 20

leads to decreased activity of the indirect pathway of the BG

Question 21

External GP cells become abnormally active reducing the

Answer 21

excitatory output of the subthalamic nucleus to the internal GP

Question 22

Inhibitory outflow of the BG reduced

Answer 22

shifting balance in favour of direct pathway and thalamic overexcitation of the frontal cortex

Question 23

In contrast, cognitive and psychiatric decline in HD

Answer 23

associated with disruption of non-motor BG loops i.e prefrontal, limbic

Question 24

According to the WHO by 2040

Answer 24

neurodegenerative diseases will have surpassed cancer to become the second leading cause of death worldwide emphasising the need for suitable treatment options to improve quality of life of individuals suffering from these debilitating conditions

Question 25

While there is currently no cure for HD

Answer 25

several treatments are available in order to manage these fatal symptoms with ongoing research into future therapeutic possibilities

Question 26

Tetrabenzazine is the only

Answer 26

drug specifically licensed to treat HD chorea

Question 27

TB acts primarily as a reversible high-affinity inhibitor of

Answer 27

monoamine uptake into granular vesicles of presynaptic neurons by binding selectively to VMAT-2

Question 28

As a result of VMAT2 inhibition

Answer 28

monoamine degradation in neuron is increased, depletion of monoamines particularly dopamine

Question 29

Side effects of TB however

Answer 29

sleep disturbances
anxiety
depression

Question 30

While antidepressants are often prescribed to manage cognitive and psych symptoms

Answer 30

In recent years researchers have become increasingly aware of potential therapies that extend beyond those commonly used to treat disorders of the CNS

Question 31

Metformin

Answer 31

widely established drug T2DM

Question 32

Gene therapy is at forefront of current research

Answer 32

with antisense oligonucleotides (ASOs) showing promise as potential treatment for HD

Question 33

ASOs consist of single stranded synthetic DNA molecules

Answer 33

that selectively bind target mRNA producing RNAse H-mediated degradation of the target

Question 34

Previous studies have demonstrated the ability of ASOs to reduce the level of mHTT mRNA in transgenic mouse models

Answer 34

While human trials initially reproduced these findings data from phase III clinical trials have proved discouraging highlighting need for further research in this area